Literature DB >> 29728404

Oral arsenic and all-trans retinoic acid for high-risk acute promyelocytic leukemia.

Hong-Hu Zhu1, Yan-Rong Liu1, Jin-Song Jia1, Ya-Zhen Qin1, Xiao-Su Zhao1, Yue-Yun Lai1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29728404     DOI： 10.1182/blood-2018-02-834051

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

1.  FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias.

Authors:  Cécile Esnault; Ramy Rahmé; Kim L Rice; Caroline Berthier; Coline Gaillard; Samuel Quentin; Anne-Lise Maubert; Scott Kogan; Hugues de Thé
Journal:  Blood       Date:  2019-01-23       Impact factor: 22.113

Review 2.  Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all.

Authors:  Maximilian Stahl; Martin S Tallman
Journal:  Leuk Lymphoma       Date:  2019-12-16

3.  A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535).

Authors:  Jeffrey E Lancet; Anna B Moseley; Steven E Coutre; Daniel J DeAngelo; Megan Othus; Martin S Tallman; Mark R Litzow; Rami S Komrokji; Harry P Erba; Frederick R Appelbaum
Journal:  Blood Adv       Date:  2020-04-28

4.  Arsenic sulfide nanoformulation induces erythroid differentiation in chronic myeloid leukemia cells through degradation of BCR-ABL.

Authors:  Tao Wang; Tao Wen; Hongmin Li; Bing Han; Suisui Hao; Chuan Wang; Qiang Ma; Jie Meng; Jian Liu; Haiyan Xu
Journal:  Int J Nanomedicine       Date:  2019-07-22

5.  JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML.

Authors:  Tracy Dagher; Nabih Maslah; Valérie Edmond; Bruno Cassinat; William Vainchenker; Stéphane Giraudier; Florence Pasquier; Emmanuelle Verger; Michiko Niwa-Kawakita; Valérie Lallemand-Breitenbach; Isabelle Plo; Jean-Jacques Kiladjian; Jean-Luc Villeval; Hugues de Thé
Journal:  J Exp Med       Date:  2021-02-01       Impact factor: 14.307

Review 6.  Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy.

Authors:  Carmelo Gurnari; Maria Teresa Voso; Katia Girardi; Angela Mastronuzzi; Luisa Strocchio
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

7.  Population Pharmacokinetics and Safety of Oral Tetra-Arsenic Tetra-Sulfide Formula in Pediatric Acute Promyelocytic Leukemia.

Authors:  Li Zhang; Xin-Mei Yang; Wei Zhao; Xiao-Fan Zhu; Jing Chen; Lei Hu; Fan Yang; Yue Zhou; Bei-Bei Zhao
Journal:  Drug Des Devel Ther       Date:  2021-04-21       Impact factor: 4.162

Review 8.  Acute promyelocytic leukemia current treatment algorithms.

Authors:  Musa Yilmaz; Hagop Kantarjian; Farhad Ravandi
Journal:  Blood Cancer J       Date:  2021-06-30       Impact factor: 11.037

Review 9.  Therapeutic Approaches for Acute Promyelocytic Leukaemia: Moving Towards an Orally Chemotherapy-Free Era.

Authors:  Zheng-Li Xu; Xiao-Jun Huang
Journal:  Front Oncol       Date:  2020-10-20       Impact factor: 6.244

10.  Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study.

Authors:  Huyong Zheng; Hui Jiang; Shaoyan Hu; Ning Liao; Diying Shen; Xin Tian; Guoping Hao; Runming Jin; Jianxin Li; Yongjun Fang; Xiuli Ju; Ansheng Liu; Ningling Wang; Xiaowen Zhai; Jiashi Zhu; Qun Hu; Limin Li; Wei Liu; Lirong Sun; Li Wang; Yunpeng Dai; Xiaoqin Feng; Fu Li; Hui Liang; Xinhui Luo; Mei Yan; Qingning Yin; Yan Chen; Yueqin Han; Lijun Qu; Yanling Tao; Hui Gao; Zhixu He; Limin Lin; Jixia Luo; Kaili Pan; Jingrong Zhang; Rong Zhang; Min Zhou; Yuanyuan Zhang; Linya Wang; Ruidong Zhang; Peifang Xiao; Yayun Ling; Xiaoxia Peng; Yaguang Peng; Tianyou Wang
Journal:  J Clin Oncol       Date:  2021-06-02       Impact factor: 50.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.